IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation
- 29 June 2020
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 473 (1-2) , 1-13
Abstract
Protein tyrosine phosphatase receptor type D (PTPRD) is a tumor suppressor gene that is epigenetically silenced and mutated in several cancers, including breast cancer. Since IL-6/STAT3 signaling is often hyperactivated in breast cancer and STAT3 is a direct PTPRD substrate, we investigated the role of PTPRD in breast cancer and the association between PTPRD and IL-6/STAT3 signaling. We found that PTPRD acts as a tumor suppressor in breast cancer tissues and that high PTPRD expression is positively associated with tumor size, lymph node metastasis, PCNA expression, and patient survival. Moreover, breast cancers with high PTPRD expression tend to exhibit high IL-6 and low phosphorylated-STAT3 expression. IL-6 was found to inhibit miR-34a transcription and induce PTPRD expression in breast cancer and breast epithelial cells, whereas PTPRD was shown to mediate activated STAT3 dephosphorylation and to be a conserved, direct target of miR-34a. IL-6-induced PTPRD upregulation was blocked by miR-34a mimics, whereas experimental PTPRD overexpression suppressed MDA-MB-231 cell migration, invasion, and epithelial to mesenchymal transition, decreased STAT3 phosphorylation, and increased miR-34a transcription. Our findings suggest that PTPRD mediates activated STAT3 dephosphorylation and is induced by the IL-6/STAT3-mediated transcriptional inhibition of miR-34a, thereby establishing a negative feedback loop that inhibits IL-6/STAT3 signaling overactivation.Keywords
Funding Information
- National Natural Science Foundation of China (grant number #81272430)
This publication has 44 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44Experimental and Therapeutic Medicine, 2011
- Oncogenes and Tumor Suppressor GenesCold Spring Harbor Perspectives in Biology, 2010
- STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to CancerMolecular Cell, 2010
- A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor geneGenes, Chromosomes and Cancer, 2010
- The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersProceedings of the National Academy of Sciences, 2009
- Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3–microRNA Cluster 17/92 PathwayCirculation Research, 2009
- Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor PrognosisPLOS Medicine, 2008
- Receptor tyrosine phosphatase–dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4 Journal of Cell Biology, 2005
- Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89Oncogene, 2004